Holdings
Jones Hill Capital LP
As of Sep 30, 2026, Jones Hill Capital LP reported 31 positions worth US$558M. Largest: BioMarin Pharmaceutical Inc., BioCryst Pharmaceuticals, Inc. and Travere Therapeutics, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| BioMarin Pharmaceutical Inc. | 1.17M | US$70.3M | −260K | Sep 30, 2026 |
| BioCryst Pharmaceuticals, Inc. | 7.08M | US$59M | new | Sep 30, 2026 |
| Travere Therapeutics, Inc. | 960K | US$56.5M | new | Sep 30, 2026 |
| Indivior Pharmaceuticals, Inc. | 1.53M | US$54.7M | new | Sep 30, 2026 |
| Celcuity Inc. | 383K | US$30.4M | new | Sep 30, 2026 |
| Ionis Pharmaceuticals, Inc. | 600K | US$26.8M | new | Sep 30, 2026 |
| Supernus Pharmaceuticals, Inc. | 602K | US$25.9M | new | Sep 30, 2026 |
| Nuvation Bio Inc. | 4.49M | US$25.1M | new | Sep 30, 2026 |
| Vera Therapeutics, Inc. | 652K | US$21.1M | new | Sep 30, 2026 |
| Trevi Therapeutics, Inc. | 1.45M | US$20.7M | +108K | Sep 30, 2026 |